| Company | Neoleukin Therapeutics |
|---|---|
| Date | 2023-03 |
| Industry | Healthcare |
| City | Seattle |
| Country | United States |
| % of Workforce | 70% |
| Status | Post-IPO |
| Company | Neoleukin Therapeutics |
|---|---|
| Date | 2023-03 |
| Industry | Healthcare |
| City | Seattle |
| Country | United States |
| % of Workforce | 70% |
| Status | Post-IPO |